Department of Pathology

Paul E. Wakely, Jr., MD


Paul E. Wakely, Jr., MD




Email Dr. Wakely

Mailing Address:

E405 Doan Hall
410 West 10th Ave.
Columbus, OH 43210


I am a board-certified surgical pathologist and cytopathologist specializing in fine needle aspiration cytopathology, head/neck pathology, and soft tissue/bone pathology. I have been in practice since 1983, and am a tenured professor in the Department. I am a frequent speaker at regional, national, and international courses regarding these subjects.

My research involves application of new technologies to the detection and diagnosis of head/neck and soft tissue/bone neoplasms. I have collaborated with the Thyroid Cancer Unit for more than 15 years. I serve as a co-Investigator for the Pathology and Clinical Correlation Core of the OSU Thyroid Cancer P01 SPORE Grant in which I have been responsible for pathology review of thyroid tissue/tumors collected from patients. I also provide thyroid cancer-specific reviews of tissues for clinical trials in thyroid cancer and also from tissue microarrays and other samples collected as part of the Endocrine Neoplasia Repository.

I am currently an associate editor of the Journal of American Society of Cytopathology, and previously served as associate editor of Cancer Cytopathology for ten years. I currently serve on the Education Committee of the U.S./Canadian Academy of Pathology, and previously served on the American Board of Pathology test development & advisory committee. Prior awards include the M-II pathology teaching award (OSU), the anatomic pathology resident teaching award (twice), and Y. Oertel Interventional Cytopathologist Award from the Papanicolaou Society of Cytopathology.

Board Certifications

1991 Cytopathology, American Board of Pathology

1990 Pediatric Pathology, American Board of Pathology

1983 Anatomic and Clinical Pathology, American Board of Pathology

1976 State of Ohio Board of Medicine

Academic and Medical Appointments

1998-Present Tenured Professor, Department of Pathology, The Ohio State University, Columbus Ohio.

2001-Present Adjunct Professor, Department of Otolaryngology,, The Ohio State University, Columbus Ohio.

Education and Training

1982-1983 Resident, Laboratory Medicine, Johns Hopkins Hospital, Johns Hopkins University School of Medicine, Baltimore, MD

1980-1982 Fellow, Pathology, Children's Hospital, U. of Cincinnati College of Medicine, Cincinnati, OH

1978-1980 Resident, Pathology, University Hospital, U. of Michigan Medical School, Ann Arbor, MI

1976-1977 Resident, Pediatrics, Children's Hospital, U. of Cincinnati College of Medicine, Cincinnati, OH

1971-1975 M.D., St. Louis University School of Medicine, St. Louis, MO

1967-1971 B.S., The Ohio State University, Columbus, OH

Selected Publications

Search in PubMed


Book Chapters:

Peer-Reviewed Publications (recent):

  • Wangsiricharoen S, Ali SZ, Wakely Jr. PE Jr. Cytopathology of myxoinflammatory fibroblastic sarcoma: A series of eight cases and review of the literature. J Am Soc Cytopathol (in press)
  • Wangsiricharoen S, Larman T, Wakely Jr. PE Jr., Siddiqui MT, Ali SZ. Cytopathology of extra-renal perivascular epithelioid cell tumor (Pecoma): A series of seven cases and review of the literature. J Am Soc Cytopathol (in press)
  • Fitzthum AD, Wakely PE Jr. Chronic lymphocytic leukemia and second primary non-lymphoid malignancies: Cytopathologic study of seventeen cases. J Am Soc Cytopathol (in press)
  • Wakely PE Jr. Cytopathology of myxofibrosarcoma: A study of 66 cases and literature review.. J Am Soc Cytopathol (in press)
  • Wakely PE Jr. Extraskeletal myxoid chondrosarcoma: combining cytopathology with molecular testing to achieve diagnostic accuracy. J Am Soc Cytopathol (in press)
  • Jin M, Chowsilpa S, Ali SZ, Wakely PE Jr. Mesenchymal neoplasms of the tubular gut and adjacent structures: experience with EUS-guided fine-needle aspiration cytopathology. J Am Soc Cytopathol 2020; 9:528-39.
  • Lott-Limbach AA, Wakely PE Jr. Mediastinal sarcomas: experience using fine needle aspiration cytopathology. Mediastinum 2020; 4:14.
  • Wolfe AR, Blakaj D, London N, Blakaj A, Klamer B, Pan J, Wakely P, Prevedello L, Bonomi M, Bhatt A, Raval R, Palmer J, Prevedello D, and Carrau R. Clinical outcomes and multidisciplinary patterns of failure for olfactory neuroblastoma: the Ohio State experience. J Neurol Surg B Skull Base. 2020;81:287-94.
  • Quiroga, D, Liebner DA, Philippon JS, Hoffman S, Tan Y, Chen JL, Lenobel S, Wakely PE Jr., Pollock R, Tinoco G. Activity of PD1 inhibitor therapy in advanced sarcoma: a single-center retrospective analysis. BMC Cancer 2020; 20:527.
  • Mustafa S, VandenBussche CJ, Ali, SZ, Siddiqui MT, and Wakely PE Jr. Cytomorphologic findings of low-grade fibromyxoid sarcoma. J Am Soc Cytopathol 2020; 9:191-201.